CClinicalTrials.gg
CompletedNCT00517088PABCUpdated May 30, 2014

Level of Physical Activities in Patients Before and After Breast Cancer Treatment

An interventional study of IPAQ in Breast Cancer, sponsored by UPECLIN HC FM Botucatu Unesp. Completed. Open to female participants aged 20 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-05-30.

Sponsored by UPECLIN HC FM Botucatu Unesp · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
2,007
Allocation
Not applicable
Ages
20 Years to 90 Years
Sex
Female
01

Study summary

Subjects and Methods: 303 patients who had already had the diagnosis of breast cancer and had already been treated at the Ambulatory of Botucatu School of Medicine were selected. The measuring tool used for the level of physical activities was the International Physical Activities Questionnaire (IPAQ-short version), validated by the World Health Organization - Physical Activities and Health International Committee (1998).

Read the detailed description

Introduction: Breast cancer is the most common malignant neoplasy in women. The risk for breast cancer in a lifetime is high among north-american women, about one out of eight, with 66% of the cases occurring after menopause and 15% when women are under 40 years old. Published cohort studies show clear evidences that women who practice intense physical activities have the risk for breast cancer reduced. The risk reduction for these women is 70%, and 10% for those who practice physical activities at a low level. During adolescence and adult age, moderate to intense physical activities may protect against a future breast cancer development. But some questions still need to be answered: Were women with a breast carcinoma diagnosis already physically active during life? Were there changes in these physical activities after treatment? Why? Objectives: The aim of this study was to identify the level of physical activities in patients before and after breast carcinoma treatment, and to observe if there were changes in the level of these activities. Subjects and Methods: 303 patients who had already had the diagnosis of breast cancer and had already been treated at the Ambulatory of Botucatu School of Medicine were selected. The measuring tool used for the level of physical activities was the International Physical Activities Questionnaire (IPAQ-short version), validated by the World Health Organization - Physical Activities and Health International Committee (1998).

02

Conditions studied

  • Breast Cancer

Browse trials for

Keywords

  • Physical Activity
  • Breast Cancer
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 2,007 is above the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

UPECLIN HC FM Botucatu Unesp is the lead sponsor of 63 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Patients whit diagnosis of breast cancer
05

Study design

Phase
Not applicable
Allocation
Not applicable
Intervention model
Single group
Masking
Single (Participant)
Enrollment
2,007 participants (actual)

Study arms

  • Other
    Other

    Group Description

    Drug: IPAQ

Interventions

  • DrugIPAQ
06

What researchers measure

Primary outcomes

  1. breast cancer

    Time frame: one year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00517088
Lead sponsor
UPECLIN HC FM Botucatu Unesp
First posted
Aug 16, 2007
Start date
May 2006
Completion
Mar 2007
Last update
May 30, 2014

Study contacts

Flávio G Pinto
principal investigator · UPECLIN HC FM Botucatu Unesp

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion